Avoid common mistakes on your manuscript.
In the past two decades, particularly since CRISPR/Cas was recognized as a genome editing tool (https://doi.org/10.1126/science.1225829), genome editing has become a powerful biotechnological tool for many biological and biomedical studies (https://doi.org/10.1631/jzus.B2100009). CRISPR/Cas-based genome editing not only edits a genome/gene sequence genetically or epigenetically but also can be used to track and monitor a specific DNA/RNA sequence. Thus, CRIPR/Cas-based genome editing currently has been widely using in many fields, particularly in agriculture for improving crop yield, quality and tolerance to various environmental stresses (https://doi.org/10.1016/j.cell.2021.01.005), and biomedicine for gene therapy (https://doi.org/10.1002/jcp.30064). In this special issue, scientists around the world reviewed not only the major achievement in genome editing, majorly focused on CRISPR/Cas, in a variety of fields, including gene therapy and plant breeding, but also CRISPR/Cas tools and their delivery system. This special issue also included several research papers, in which scientists employed CRISPR/Cas and TALEN system to knockout an individual gene for studying Parkinson’s disease and improving epothilone D yield.
Many people contributed significantly to this successful special issue. I would first like to thank the support from the entire genome editing community, especially the authors and anonymous reviewers. I also appreciate the strong support from the Publishing Editor, Ingrid Fischer and the Editor-in-Chief, Dr. Giancarlo Basile. Finally, I have also had the honor and pleasure of serving Molecular Biotechnology as editor and then associate editor for more than one decade. This has been a truly wonderful experience in my research and education career.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, B. Genome Editing. Mol Biotechnol 65, 137 (2023). https://doi.org/10.1007/s12033-022-00622-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12033-022-00622-w